MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0008232
Bilberry Pharmaceuticals Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.62 Cr
▲ 67% YoY
Net profit · FY 2024
₹3.33 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹23.94 Lakh
EBITDA margin 3.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹1.35 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
21
Provident fund records
About Bilberry Pharmaceuticals Private Limited
Data last updated:
Bilberry Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24299MP2016PTC041803. Its GSTIN is 23AAHCB0160E1ZD (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Devendra Kumar Pathak and Roshni Pathak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Green Velly Flat No.C – 507 Kanadiya Road, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.62 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹3.33 Lakh (net margin 0.5%) and EBITDA of ₹23.94 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 58% over three years and 46% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bilberry Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.35 Cr on record.
Bilberry Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0008232). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bilberry.in.
Company details
CIN U24299MP2016PTC041803
Registration Number 041803
Incorporation Date 08 November 2016
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0008232
Recognitions & Rankings of Bilberry Pharmaceuticals
Contact details
Bilberry Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its website is bilberry.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGreen Velly Flat No.C – 507 Kanadiya Road, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bilberry Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bilberry Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bilberry Pharmaceuticals operates one associated brand: Bilberry Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of quality ethical drugs and pharmaceuticals with a focus on assurance systems. | bilberry.in |
Business activity
The main business activity of Bilberry Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bilberry Pharmaceuticals Private Limited, buy the company report.
Financials of Bilberry Pharmaceuticals Private Limited
FY 2025 filings availableBilberry Pharmaceuticals Private Limited reported revenue of ₹6.62 Cr (up 67% YoY) for FY 2024.
Revenue · FY 2024
₹6.62 Cr ▲ 67%
Net profit · FY 2024
₹3.33 Lakh margin 0.5%
EBITDA · FY 2024
₹23.94 Lakh margin 3.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 58%
5 years · compounded
▲ 46%
EBITDA CAGR growth
1 year
▲ 93%
3 years · compounded
▲ 62%
5 years · compounded
▲ 30%
Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 67% growth in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bilberry Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bilberry Pharmaceuticals Private Limited
Bilberry Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devendra Kumar Pathak | Director | 08 Nov 2016 | 9 Years 11 Months | Current |
| Roshni Pathak Also directs: Master's Summit Foundation | Director | 17 Nov 2016 | 9 Years 11 Months | Current |
Peer comparison
Bilberry Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| TPPL Pharmaceuticals Private Limited | ₹6.69 Cr (FY 2025) | -3.0% | Jaipur, Rajasthan, India | |||
| Ostrich Pharmaceuticals Private Limited | ₹6.63 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Bilberry Pharmaceuticals Private Limitedthis company | ₹6.62 Cr (FY 2024) | ₹3.33 Lakh | 0.5% | 67.0% | 21 | Indore, Madhya Pradesh, India |
| Alwin Willcure Pharmaceuticals Private Limited | ₹6.52 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Genesia Pharmaceuticals (India) Private Limited | ₹6.51 Cr (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Grahams Pharmaceuticals Private Limited | ₹6.5 Cr (FY 2024) | -12.0% | Kochi, Kerala, India |
To see the full peer comparison of Bilberry Pharmaceuticals Private Limited, buy the company report.
Auditor
Bilberry Pharmaceuticals Private Limited is audited by ABV & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABV & Company | FY 2023 | 134179W |
Shareholding
The shareholding of Bilberry Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bilberry Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.35 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2024 | 100851217 | Tata Capital Housing Finance Limited | ₹1.35 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Bilberry Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bilberry Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bilberry Pharmaceuticals Private Limited has a workforce of 21 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
21
Active EPFO establishments
1
Employee growth
-25%
GST
Bilberry Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAHCB0160E1ZD | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bilberry Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bilberry Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Roshni Pathak ceased to be Additional Director on 20 Dec 2017.
AGM
Bilberry Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bilberry Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Tata Capital Housing Finance Limited amounted to Rs. 135.00 Lakh with Charge ID 100851217 was registered on 24 Jan 2024.
Ceased
Roshni Pathak ceased to be Additional Director.
Ceased
Amod Kumar Singh ceased to be Director.
Appointed
Roshni Pathak was appointed as Director.
Appointed
Devendra Kumar Pathak was appointed as Director.
Incorporation
08 Nov 2016
Bilberry Pharmaceuticals Private Limited was registered on 08 Nov 2016 with Roc Gwalior & aged 9 years 11 months as per MCA records.
Frequently asked questions
Bilberry Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 2016 (10+ years old) and is registered under CIN U24299MP2016PTC041803.
Bilberry Pharmaceuticals has 2 current directors:
- Devendra Kumar Pathak - Director
- Roshni Pathak - Director
The latest financial statements of Bilberry Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Bilberry Pharmaceuticals is 23AAHCB0160E1ZD, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Bilberry Pharmaceuticals is U24299MP2016PTC041803. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bilberry Pharmaceuticals was incorporated on 08 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Bilberry Pharmaceuticals by revenue are TPPL Pharmaceuticals Private Limited, Ostrich Pharmaceuticals Private Limited, Alwin Willcure Pharmaceuticals Private Limited, Genesia Pharmaceuticals (India) Private Limited, Grahams Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Roshni Pathak ceased to be Additional Director on 20 Dec 2017. Amod Kumar Singh ceased to be Director on 17 Nov 2016. Roshni Pathak was appointed as Director on 17 Nov 2016. Bilberry Pharmaceuticals has 4 board changes on record in total.
Yes, Bilberry Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0008232).
Bilberry Pharmaceuticals can be reached through the website bilberry.in. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Bilberry Pharmaceuticals is at Green Velly Flat No.C – 507 Kanadiya Road, Indore, Madhya Pradesh, India – 452001.